These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32578579)

  • 1. Development and validation of psoriatic arthritis switch quality assessment tool (PASQAL) - an outcomes measurement tool to assess the quality of biologic switch decisions in psoriatic arthritis.
    Laires PA; Carrilho M; Tavares-Costa J; Lucas P; Machado P; Cunha-Miranda L; Pimentel-Santos F; Santos H; Vieira-Sousa E; Santos MJ
    Acta Reumatol Port; 2020; 45(1):46-57. PubMed ID: 32578579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA).
    Lapadula G; Marchesoni A; Salaffi F; Ramonda R; Salvarani C; Punzi L; Costa L; Caso F; Simone D; Baiocchi G; Scioscia C; Di Carlo M; Scarpa R; Ferraccioli G
    Reumatismo; 2016 Dec; 68(3):126-136. PubMed ID: 27981814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching biologics in the treatment of psoriatic arthritis.
    Merola JF; Lockshin B; Mody EA
    Semin Arthritis Rheum; 2017 Aug; 47(1):29-37. PubMed ID: 28363434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis.
    Wu JJ; Pelletier C; Ung B; Tian M; Khilfeh I; Curtis JR
    Adv Ther; 2020 May; 37(5):2098-2115. PubMed ID: 32141018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expert Consensus on a Set of Outcomes to Assess the Effectiveness of Biologic Treatment in Psoriatic Arthritis: The MERECES Study.
    Cañete JD; Nolla JM; Queiro R; Rodríguez MJ; Ruiz M; Lizán L;
    J Rheumatol; 2020 Nov; 47(11):1637-1643. PubMed ID: 32007930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.
    Smolen JS; Schöls M; Braun J; Dougados M; FitzGerald O; Gladman DD; Kavanaugh A; Landewé R; Mease P; Sieper J; Stamm T; Wit M; Aletaha D; Baraliakos X; Betteridge N; Bosch FVD; Coates LC; Emery P; Gensler LS; Gossec L; Helliwell P; Jongkees M; Kvien TK; Inman RD; McInnes IB; Maccarone M; Machado PM; Molto A; Ogdie A; Poddubnyy D; Ritchlin C; Rudwaleit M; Tanew A; Thio B; Veale D; Vlam K; van der Heijde D
    Ann Rheum Dis; 2018 Jan; 77(1):3-17. PubMed ID: 28684559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Saudi consensus recommendations for the management of psoriatic arthritis (2023).
    Al-Homood IA; Al Ghanim N; Fatani MIA; Hussein AH; Alolaiwi AM; Abualiat A; Alqurtas E; Alomari BAA; Khardaly AM; Alenzi KAO; Albarakati RG; Almudaiheem HY; Al-Jedai A; Eshmawi MTY
    Clin Rheumatol; 2024 Mar; 43(3):879-894. PubMed ID: 38217738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Singapore Chapter of Rheumatologists consensus statement on the eligibility for government subsidy of biologic disease modifying anti-rheumatic agents for the treatment of psoriatic arthritis.
    Lahiri M; Teng GG; Cheung PP; Suresh E; Chia FL; Lui NL; Koh DR; Koh WH; Leong KP; Lim AYN; Ng SC; Thumboo J; Lau TC; Leong KH
    Int J Rheum Dis; 2017 Oct; 20(10):1527-1540. PubMed ID: 26353916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology.
    Salvarani C; Pipitone N; Marchesoni A; Cantini F; Cauli A; Lubrano E; Punzi L; Scarpa R; Spadaro A; Matucci-Cerinic M; Olivieri I;
    Clin Exp Rheumatol; 2011; 29(3 Suppl 66):S28-41. PubMed ID: 21906425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A national survey on the management of psoriatic arthritis using the Delphi method.
    Lubrano E; Cantini F; Mathieu A; Olivieri I; Salvarani C; Scarpa R; Marchesoni A
    Clin Exp Rheumatol; 2017; 35(2):214-220. PubMed ID: 27607572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus statements for pharmacological management, monitoring of therapies, and comorbidity management of psoriatic arthritis in the United Arab Emirates.
    Alnaqbi KA; Hannawi S; Namas R; Alshehhi W; Badsha H; Al-Saleh J
    Int J Rheum Dis; 2022 Oct; 25(10):1107-1122. PubMed ID: 35916205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus-based recommendations on the diagnosis, referral and clinical management of patients with psoriatic arthritis.
    Al Rayes H; Alazmi M; Attar S; Alderaan K; Alghamdi M; Alghanim N; Alhazmi A; Alkhadhrawi N; Almohideb M; Alzahrani Z; Bedaiwi M; Halabi H
    Rheumatol Int; 2022 Mar; 42(3):391-401. PubMed ID: 34716785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain.
    Gratacós J; Luelmo J; Rodríguez J; Notario J; Marco TN; de la Cueva P; Busquets MP; Font MG; Joven B; Rivera R; Vega JLA; Álvarez AJC; Parera RS; Carrascosa JCR; Martínez FJR; Sánchez JP; Olmos CF; Pujol C; Galindez E; Barrio SP; Arana AU; Hergueta M; Coto P; Queiro R
    Rheumatol Int; 2018 Jun; 38(6):1115-1124. PubMed ID: 29417210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials.
    Perez-Chada LM; Gottlieb AB; Cohen J; Mease P; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
    J Am Acad Dermatol; 2020 Jan; 82(1):54-61. PubMed ID: 31163240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis.
    Kavanaugh A; Singh R; Karki C; Etzel CJ; Kremer JM; Greenberg JD; Griffith J
    Clin Rheumatol; 2018 Aug; 37(8):2275-2280. PubMed ID: 29869112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current approach to the management of psoriatic arthritis according to a sample of Italian rheumatologists.
    Marchesoni A; Lubrano E; Manara M; Ramonda R; Salvarani C; Olivieri I
    Clin Exp Rheumatol; 2016; 34(6):1051-1058. PubMed ID: 27462870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis.
    Machado P; Bogas M; Ribeiro A; Costa J; Neto A; Sepriano A; Raposo A; Cravo AR; Vilar A; Furtado C; Ambrósio C; Miguel C; Vaz C; Catita C; Nour D; Araújo D; Vieira-Sousa E; Teixeira F; Brandão F; Canhão H; Cordeiro I; Gonçalves I; Ferreira J; Fonseca JE; da Silva JA; Romeu J; Ferreira J; Costa L; Maurício L; Cunha-Miranda L; Parente M; Coutinho M; Cruz M; Oliveira M; Salvador MJ; Santos MJ; Pinto P; Valente P; Abreu P; Roque R; Ramiro S; Capela S; Las V; Barcelos A;
    Acta Reumatol Port; 2012; 37(1):26-39. PubMed ID: 22781512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PORTUGUESE RECOMMENDATIONS FOR THE USE OF BIOLOGICAL THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS--2015 UPDATE.
    Vieira-Sousa E; Machado PM; Costa J; Ribeiro A; Aguiar R; Cerqueira M; Neto A; Bernardo A; Cordeiro A; Duarte C; Vinagre F; Canhão H; Santos H; Neves JS; Cunha-Miranda L; Silva M; Santos MJ; Bernardes M; Bogas M; Abreu P; Viana-Queiroz M; Barros R; Falcão S; Pimenta S; Teixeira V; Fonseca JE; Barcelos A;
    Acta Reumatol Port; 2015; 40(3):275-90. PubMed ID: 26610694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apremilast for biologic-naïve, peripheral psoriatic arthritis, including patients with early disease: results from the APROACH observational prospective study.
    Sfikakis PP; Vassilopoulos D; Katsifis G; Vosvotekas G; Dimitroulas T; Sidiropoulos P; Vounotrypidis P; Bogdanos DP; Georgountzos AΙ; Bounas AG; Georgiou P; Gazi S; Kataxaki E; Liossis SN; Theodorou E; Papagoras C; Theotikos E; Vlachoyiannopoulos P; Voulgari PV; Kekki A; Antonakopoulos N; Boumpas DT
    Rheumatol Int; 2023 May; 43(5):889-902. PubMed ID: 36856816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire.
    Coates LC; Orbai AM; Azevedo VF; Cappelleri JC; Steinberg K; Lippe R; Lim I; Eder L; Richette P; Weng MY; Queiro Silva R; Fallon L
    Health Qual Life Outcomes; 2020 Jun; 18(1):173. PubMed ID: 32513190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.